Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

4.3%

1 terminated out of 23 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

35%

8 trials in Phase 3/4

Results Transparency

14%

2 of 14 completed with results

Key Signals

2 with results93% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (7)
Early P 1 (1)
P 1 (1)
P 2 (1)
P 3 (4)
P 4 (4)

Trial Status

Completed14
Recruiting4
Unknown3
Active Not Recruiting1
Terminated1

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06875947Not ApplicableActive Not RecruitingPrimary

EFFECTS of MORINGA OLEIFERA LEAF POWDERS on HEMATOLOGICAL PROFILES IN PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

NCT07083492RecruitingPrimary

Non-invasive Detection of Iron Deficiency in Obstetrics

NCT04008147Not ApplicableRecruitingPrimary

Hepcidin and Glucose Metabolism

NCT05545527Completed

Neuroimaging Ancillary Study

NCT06425796Not ApplicableRecruitingPrimary

Adiposity and Iron Requirements in Pregnancy

NCT04074707Not ApplicableCompletedPrimary

Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy

NCT04594070Phase 4Terminated

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

NCT03438227Phase 4CompletedPrimary

Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial

NCT03961074CompletedPrimary

Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study

NCT06366698Phase 3RecruitingPrimary

Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia

NCT04976179Phase 3CompletedPrimary

Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)

NCT05804071Phase 4UnknownPrimary

Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy

NCT05725278Not ApplicableCompleted

Impact Evaluation of Triggerise's Tiko Platform

NCT03657433Phase 3CompletedPrimary

Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy

NCT05157828CompletedPrimary

Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care

NCT05151679UnknownPrimary

Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy

NCT03188445Phase 4CompletedPrimary

Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.

NCT03706638Not ApplicableCompletedPrimary

Daily vs Intermittent Iron Therapy in Pregnancy

NCT03484845Phase 1UnknownPrimary

Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy

NCT03481790Phase 2CompletedPrimary

Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy

Scroll to load more

Research Network

Activity Timeline